InvestorsHub Logo
Followers 826
Posts 119569
Boards Moderated 14
Alias Born 09/05/2002

Re: None

Monday, 05/09/2016 10:26:07 AM

Monday, May 09, 2016 10:26:07 AM

Post# of 232
MDCO divests Cleviprex and Kengreal for $260M cash up-front and $480M in contingent sales-based milestones:

http://finance.yahoo.com/news/medicines-company-agrees-divest-non-110000769.html

Note: MDCO has retained Angiomax.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”